J Bréard

3.3k total citations · 1 hit paper
22 papers, 2.9k citations indexed

About

J Bréard is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, J Bréard has authored 22 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in J Bréard's work include Immune Cell Function and Interaction (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (5 papers). J Bréard is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (5 papers). J Bréard collaborates with scholars based in France, United States and Italy. J Bréard's co-authors include Ellis L. Reinherz, S F Schlossman, Patrick C. Kung, Gideon Goldstein, Leonard Chess, Stuart F. Schlossman, Caroline Paris, Christian Bories, Philippe M. Loiseau and Stephen M. Krane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

J Bréard

22 papers receiving 2.5k citations

Hit Papers

A monoclonal antibody reactive with human peripheral bloo... 1980 2026 1995 2010 1980 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Bréard France 17 1.3k 756 649 448 383 22 2.9k
Enrique Rabellino United States 22 1.8k 1.3× 582 0.8× 664 1.0× 800 1.8× 262 0.7× 29 3.1k
Wendy F. Davidson United States 34 2.1k 1.5× 1.1k 1.4× 491 0.8× 190 0.4× 391 1.0× 69 3.6k
P E Lipsky United States 31 2.2k 1.6× 841 1.1× 551 0.8× 282 0.6× 455 1.2× 46 3.6k
Göran Holm Sweden 25 1.7k 1.3× 522 0.7× 367 0.6× 610 1.4× 398 1.0× 53 2.6k
Susan R. Webb United States 28 3.5k 2.6× 605 0.8× 819 1.3× 222 0.5× 438 1.1× 47 4.4k
Bernard J. Scallon United States 28 1.5k 1.1× 1.3k 1.7× 1.0k 1.6× 387 0.9× 368 1.0× 38 3.9k
W.J.M. Tax Netherlands 26 1.7k 1.3× 860 1.1× 985 1.5× 220 0.5× 362 0.9× 77 2.7k
Frans M.A. Hofhuis Netherlands 21 1.7k 1.3× 1.3k 1.8× 828 1.3× 229 0.5× 435 1.1× 57 3.2k
P J Lachmann United Kingdom 29 1.8k 1.3× 543 0.7× 435 0.7× 840 1.9× 157 0.4× 76 2.9k
J H Vaughan United States 39 2.2k 1.6× 664 0.9× 1.3k 2.1× 394 0.9× 851 2.2× 89 4.3k

Countries citing papers authored by J Bréard

Since Specialization
Citations

This map shows the geographic impact of J Bréard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Bréard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Bréard more than expected).

Fields of papers citing papers by J Bréard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Bréard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Bréard. The network helps show where J Bréard may publish in the future.

Co-authorship network of co-authors of J Bréard

This figure shows the co-authorship network connecting the top 25 collaborators of J Bréard. A scholar is included among the top collaborators of J Bréard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Bréard. J Bréard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bréard, J, et al.. (2013). Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737. Cell Death and Disease. 4(9). e801–e801. 31 indexed citations
3.
Paris, Caroline, Philippe M. Loiseau, Christian Bories, & J Bréard. (2004). Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes. Antimicrobial Agents and Chemotherapy. 48(3). 852–859. 270 indexed citations
4.
Pallardy, Marc, et al.. (1998). Apoptosis: Identification of dying cells. Cell Biology and Toxicology. 14(2). 111–120. 206 indexed citations
5.
Droin, Nathalie, Laurence Dubrez, Béatrice Eymin, et al.. (1998). Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene. 16(22). 2885–2894. 71 indexed citations
6.
Bréard, J & E Brambilla. (1997). [Apoptosis: practical approach].. PubMed. 17 Suppl 5. 61–3. 1 indexed citations
8.
Blazsek, I, et al.. (1991). Elliptinium, norcantharidin and tetrachlordecaoxide in combined chemo-immunotherapy prolong the survival of Friend-virus-infected mice.. PubMed. 17(9). 419–26. 3 indexed citations
9.
Bravo‐Cuéllar, Alejandro, et al.. (1989). In vivo immunopharmacological properties of the traditional Chinese medicine Kang Fu-Xin (KFX). 5(1). 25–33. 1 indexed citations
10.
Consolini, Rita, J Bréard, Aldar S. Bourinbaiar, et al.. (1986). Abnormal in vitro differentiation of peripheral blood clonogenic B cells in common acute lymphoblastic leukemia during complete remission. Blood. 67(3). 796–801. 8 indexed citations
11.
Bréard, J, et al.. (1986). A monoclonal antibody reactive with human eosinophils. Blood. 67(1). 50–55. 33 indexed citations
12.
Saito, Hirohisa, et al.. (1985). Establishment and characterization of a new human eosinophilic leukemia cell line. Blood. 66(6). 1233–1240. 114 indexed citations
13.
Posner, Marshall R., Ellis L. Reinherz, J Bréard, et al.. (1981). Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease. Cancer. 48(5). 1170–1176. 53 indexed citations
14.
Reinherz, Ellis L., Lorenzo Moretta, M Röper, et al.. (1980). Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison.. The Journal of Experimental Medicine. 151(4). 969–974. 367 indexed citations
15.
Lipton, Jeffrey M., et al.. (1980). Monocytes do not inhibit peripheral blood erythroid burst forming unit colony formation.. Journal of Clinical Investigation. 65(1). 219–223. 19 indexed citations
16.
Bréard, J, Ellis L. Reinherz, Patrick C. Kung, Gideon Goldstein, & S F Schlossman. (1980). A monoclonal antibody reactive with human peripheral blood monocytes.. The Journal of Immunology. 124(4). 1943–1948. 757 indexed citations breakdown →
17.
Dayer, Jean‐Michel, J Bréard, Leonard Chess, & Stephen M. Krane. (1979). Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.. Journal of Clinical Investigation. 64(5). 1386–1392. 246 indexed citations
18.
Nathan, David G., Leonard Chess, Diane G. Hillman, et al.. (1978). Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro.. The Journal of Experimental Medicine. 147(2). 324–339. 268 indexed citations
19.
Evans, Robert L., J Bréard, Herbert Lazarus, Stuart F. Schlossman, & Leonard Chess. (1977). Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens.. The Journal of Experimental Medicine. 145(1). 221–233. 125 indexed citations
20.
Friedman, Steven, J Bréard, Robert E. Humphreys, et al.. (1977). Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p23, 30 antigen.. Proceedings of the National Academy of Sciences. 74(2). 711–715. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026